Clinical Trial Detail

NCT ID NCT01823198
Title Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors M.D. Anderson Cancer Center
Indications

chronic myeloid leukemia

bone marrow cancer

acute myeloid leukemia

Therapies

Methotrexate

Busulfan + Fludarabine + anti-thymocyte globulin

Tacrolimus

Filgrastim

Age Groups: child adult

No variant requirements are available.